NKGen Biotech, Inc. Quarterly Depreciation in USD from Q3 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
NKGen Biotech, Inc. quarterly/annual Depreciation history and growth rate from Q3 2022 to Q2 2024.
  • NKGen Biotech, Inc. Depreciation for the quarter ending June 30, 2024 was $300K, a 50% decline year-over-year.
  • NKGen Biotech, Inc. Depreciation for the twelve months ending June 30, 2024 was $800K.
  • NKGen Biotech, Inc. annual Depreciation for 2023 was $1.1M, a 8.33% decline from 2022.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $800K $300K -$300K -50% Apr 1, 2024 Jun 30, 2024 10-Q 2024-09-12
Q1 2024 $1.1M $300K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 $1.1M -$100K Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 $300K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $600K Apr 1, 2023 Jun 30, 2023 10-Q 2024-09-12
Q1 2023 $300K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q3 2022 $300K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.